Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Triphosgene Mediated Protection and Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100569790C reveals a high-yield 3-step route for Capecitabine intermediates using triphosgene, offering significant cost reduction and scalability for pharmaceutical manufacturing.